{"id":"https://openalex.org/W2053575424","doi":"https://doi.org/10.1097/olq.0b013e31816766af","title":"Phase I Clinical Trial of Repeat Dose Terameprocol Vaginal Ointment in Healthy Female Volunteers","display_name":"Phase I Clinical Trial of Repeat Dose Terameprocol Vaginal Ointment in Healthy Female Volunteers","publication_year":2008,"publication_date":"2008-06-01","ids":{"openalex":"https://openalex.org/W2053575424","doi":"https://doi.org/10.1097/olq.0b013e31816766af","mag":"2053575424","pmid":"https://pubmed.ncbi.nlm.nih.gov/18418294"},"language":"en","primary_location":{"id":"doi:10.1097/olq.0b013e31816766af","doi":"https://doi.org/10.1097/olq.0b013e31816766af","is_oa":false,"landing_page_url":"https://doi.org/10.1097/olq.0b013e31816766af","pdf_url":null,"source":{"id":"https://openalex.org/S170339494","display_name":"Sexually Transmitted Diseases","issn_l":"0148-5717","issn":["0148-5717","1537-4521"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sexually Transmitted Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103165922","display_name":"Niharika Khanna","orcid":"https://orcid.org/0000-0002-3247-6762","observed_orcids":["https://orcid.org/0000-0002-3247-6762"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Niharika Khanna","raw_affiliation_strings":["Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. nkhanna@umaryland.edu","Department of Family and Community Medicine, \u2020Experimental Therapeutics Program at the Greenebaum Cancer Center, University of Maryland School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. nkhanna@umaryland.edu","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Department of Family and Community Medicine, \u2020Experimental Therapeutics Program at the Greenebaum Cancer Center, University of Maryland School of Medicine","institution_ids":["https://openalex.org/I4390039317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037950482","display_name":"Richard N. Dalby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Dalby","raw_affiliation_strings":["Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103552334","display_name":"Alyson L. Connor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alyson Connor","raw_affiliation_strings":["Pharmaceutical Profiles, Nottingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Profiles, Nottingham, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ann Church","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann Church","raw_affiliation_strings":["Pharmaceutical Profiles, Nottingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Profiles, Nottingham, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054711718","display_name":"Jennifer Stern","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Stern","raw_affiliation_strings":["Erimos Pharmaceuticals, Raleigh, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erimos Pharmaceuticals, Raleigh, North Carolina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015168638","display_name":"Neil Frazer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neil Frazer","raw_affiliation_strings":["Erimos Pharmaceuticals, Raleigh, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erimos Pharmaceuticals, Raleigh, North Carolina","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103165922"],"corresponding_institution_ids":["https://openalex.org/I126744593","https://openalex.org/I4390039317"],"apc_list":null,"apc_paid":null,"fwci":1.3319,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.80570796,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"35","issue":"6","first_page":"577","last_page":"582"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.6460000276565552,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.6460000276565552,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.23849999904632568,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vaginal-microbicides","display_name":"vaginal microbicides","score":0.8130000233650208},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.6940000057220459},{"id":"https://openalex.org/keywords/human-papillomavirus","display_name":"human papillomavirus","score":0.7929999828338623},{"id":"https://openalex.org/keywords/herpes-simplex-virus","display_name":"herpes simplex virus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7879999876022339},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.43700000643730164},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.6660000085830688},{"id":"https://openalex.org/keywords/healthy-women","display_name":"healthy women","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9308454990386963},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8035097718238831},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7666594386100769},{"id":"https://openalex.org/C97228660","wikidata":"https://www.wikidata.org/wiki/Q7908502","display_name":"Vaginal microbicide","level":5,"score":0.7447718381881714},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7390922904014587},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7201053500175476},{"id":"https://openalex.org/C197746943","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Microbicide","level":3,"score":0.7108426094055176},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6580920219421387},{"id":"https://openalex.org/C2778723060","wikidata":"https://www.wikidata.org/wiki/Q6058566","display_name":"Intravaginal administration","level":3,"score":0.5566189289093018},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5335249304771423},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.4857533276081085},{"id":"https://openalex.org/C3019340110","wikidata":"https://www.wikidata.org/wiki/Q525512","display_name":"Sexual transmission","level":4,"score":0.4120435118675232},{"id":"https://openalex.org/C2777744392","wikidata":"https://www.wikidata.org/wiki/Q5880","display_name":"Vagina","level":2,"score":0.34673333168029785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34544482827186584},{"id":"https://openalex.org/C117214928","wikidata":"https://www.wikidata.org/wiki/Q7905570","display_name":"Microbicides for sexually transmitted diseases","level":4,"score":0.29979702830314636},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.24400606751441956},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.2013475000858307},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1829814612865448},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.07354000210762024},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2986740045","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health services","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000282","descriptor_name":"Administration, Intravaginal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009637","descriptor_name":"Masoprocol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009637","descriptor_name":"Masoprocol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009637","descriptor_name":"Masoprocol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009637","descriptor_name":"Masoprocol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009824","descriptor_name":"Ointments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014621","descriptor_name":"Vagina","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015229","descriptor_name":"Sexually Transmitted Diseases, Viral","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/olq.0b013e31816766af","doi":"https://doi.org/10.1097/olq.0b013e31816766af","is_oa":false,"landing_page_url":"https://doi.org/10.1097/olq.0b013e31816766af","pdf_url":null,"source":{"id":"https://openalex.org/S170339494","display_name":"Sexually Transmitted Diseases","issn_l":"0148-5717","issn":["0148-5717","1537-4521"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sexually Transmitted Diseases","raw_type":"journal-article"},{"id":"pmid:18418294","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18418294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sexually transmitted diseases","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1494220655","https://openalex.org/W1623642640","https://openalex.org/W1986041119","https://openalex.org/W1986098326","https://openalex.org/W1987330572","https://openalex.org/W1988706339","https://openalex.org/W1991093313","https://openalex.org/W2002210849","https://openalex.org/W2011043124","https://openalex.org/W2012389772","https://openalex.org/W2024213191","https://openalex.org/W2042215225","https://openalex.org/W2042855100","https://openalex.org/W2054021971","https://openalex.org/W2056583254","https://openalex.org/W2058248138","https://openalex.org/W2059473154","https://openalex.org/W2078191149","https://openalex.org/W2083182154","https://openalex.org/W2092948870","https://openalex.org/W2106307920","https://openalex.org/W2106853491","https://openalex.org/W2116165373","https://openalex.org/W2125058204","https://openalex.org/W2125678197","https://openalex.org/W2126477537","https://openalex.org/W2128556228","https://openalex.org/W2140066941","https://openalex.org/W2145257291","https://openalex.org/W2147106111","https://openalex.org/W2166916078","https://openalex.org/W6680692503","https://openalex.org/W7157156698"],"related_works":["https://openalex.org/W2092948870","https://openalex.org/W2163151364","https://openalex.org/W2083205410","https://openalex.org/W2078702893","https://openalex.org/W2142394634","https://openalex.org/W1986420453","https://openalex.org/W2419674089","https://openalex.org/W2269473141","https://openalex.org/W2042855100","https://openalex.org/W2017638217"],"abstract_inverted_index":{"OBJECTIVES:":[0],"This":[1],"safety":[2,188],"study":[3,54,99],"of":[4,33,55,83,97,133,198],"terameprocol":[5,58,200],"(also":[6],"called":[7],"M4N,":[8],"EM-1421)":[9],"daily":[10,172],"vaginal":[11,87],"application":[12,19,197],"in":[13,23,68,153,155,201],"healthy":[14,69],"women":[15],"explores":[16],"its":[17],"potential":[18],"as":[20],"a":[21,131,164],"microbicide":[22],"interrupting":[24],"human":[25,34],"immunodeficiency":[26],"virus":[27,39],"sexual":[28],"transmission":[29],"and":[30,36,51,81,106,110,128,181],"additional":[31],"interruption":[32],"papillomavirus":[35],"herpes":[37],"simplex":[38],"transmission.":[40],"METHODS:":[41],"A":[42],"double-blind":[43],"placebo":[44],"controlled":[45],"phase":[46],"I":[47],"repeat":[48],"dose":[49,167],"tolerability":[50],"pharmacokinetic,":[52],"crossover":[53],"90":[56,165],"mg":[57,166],"(2%":[59,168],"w/w":[60],"ointment)":[61],"administered":[62,170],"intravaginally":[63],"for":[64,173],"7":[65,82,96,174],"consecutive":[66],"days":[67,79],"female":[70],"subjects.":[71],"The":[72,143,186],"pharmacokinetics":[73],"after":[74],"administration":[75],"was":[76,118,147,150,160],"examined":[77],"on":[78,94],"1":[80],"dosing.":[84],"Subjects":[85],"underwent":[86],"examination":[88],"following":[89],"the":[90,114,196],"6-hour":[91],"pharmacokinetic":[92,156],"sample":[93],"day":[95],"each":[98],"period.":[100],"RESULTS:":[101],"Recruitment":[102],"started":[103],"January":[104],"2006":[105],"ended":[107],"May":[108],"2006,":[109],"14":[111],"subjects":[112],"completed":[113],"study.":[115],"Median":[116],"age":[117],"24":[119],"years.":[120],"No":[121,176],"treatment-related":[122],"serious":[123,177],"adverse":[124,136,178],"events":[125,137,179],"were":[126,130,184],"reported,":[127],"there":[129],"total":[132],"17":[134],"treatment-emergent":[135],"(AE)":[138],"reported":[139],"by":[140],"11":[141],"participants.":[142],"most":[144],"common":[145],"AE":[146],"headache.":[148],"Terameprocol":[149,159],"not":[151],"detectable":[152],"serum":[154],"samples.":[157],"CONCLUSIONS:":[158],"well":[161],"tolerated":[162],"at":[163],"wt/wt)":[169],"vaginally":[171],"days.":[175],"occurred":[180],"any":[182],"AEs":[183],"mild.":[185],"excellent":[187],"profile":[189],"supports":[190],"future":[191],"clinical":[192],"trial":[193],"to":[194],"evaluate":[195],"intravaginal":[199],"women.":[202]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}